METHOXYPROMAZINE IN CHRONIC SCHIZOPHRENIA
MAX APFELDORF PH.D.,
HANS G. BAUER M.D., , and
THOMAS H. MCGAVACK M.D.1
1 The VA Center, Martinsburg, W. Va.
No appreciable change in adjustment was noted in 12 chronically ill schizophrenics who were subjects of a 6-month double blind study with methoxypromazine. No toxic or untoward side effects were noted with doses ranging from 100 to 600 mg. daily.
